Insider Trading History of Mccorkle Douglas S

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Mccorkle Douglas S since 2007. The trader's CIK number is 1403178. At the time of the last reporting, Mccorkle Douglas S was the VP, Controller and A of Regeneron Pharmaceuticals, Inc.. (stock ticker symbol REGN). Also see all insider trading activities at Regeneron Pharmaceuticals, Inc..



Yearly summary of insider trading at Regeneron Pharmaceuticals, Inc. (REGN) by Mccorkle Douglas S

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 REGN 0 $0 24,954 $13,063,219 24,339 $3,069,929
2014 REGN 0 $0 24,180 $8,608,735 27,661 $1,009,907
2013 REGN 0 $0 5,342 $1,198,906 11,750 $485,627
2012 REGN 0 $0 29,332 $3,699,102 59,750 $1,297,023
2011 REGN 0 $0 20,000 $800,212 20,000 $406,400
2010 REGN 0 $0 5,875 $164,500 5,875 $62,069
2009 REGN 0 $0 2,456 $54,032 2,456 $20,876
2008 REGN 0 $0 32,664 $707,898 32,664 $371,304
2007 REGN 0 $0 6,209 $130,407 6,209 $54,310


Insider trading of Regeneron Pharmaceuticals, Inc. (REGN) by Mccorkle Douglas S

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-12-29 REGN Option Ex 3,954 52.03 205,726
2015-12-29 REGN Sale 3,954 552.08 2,182,924
2015-12-16 REGN Option Ex 1,921 52.03 99,949
2015-08-05 REGN Option Ex 5,000 270.43 1,352,150
2015-08-05 REGN Sale 5,000 585.75 2,928,775
2015-05-22 REGN Option Ex 13,464 104.88 1,412,104
2015-05-22 REGN Sale 13,000 515.60 6,702,800
2015-02-27 REGN Sale 3,000 416.24 1,248,720
2014-12-17 REGN Option Ex 2,800 30.63 85,764
2014-12-15 REGN Option Ex 1,668 30.63 51,090
2014-12-16 REGN Option Ex 6,818 41.33 281,787
2014-12-15 REGN Sale 1,668 412.65 688,305
2014-12-16 REGN Sale 6,818 410.00 2,795,380
2014-08-27 REGN Option Ex 1,681 25.94 43,605
2014-08-18 REGN Sale 5,875 353.00 2,073,875
2014-08-18 REGN Option Ex 5,875 52.03 305,676
2014-02-20 REGN Option Ex 3,000 21.25 63,750
2014-02-11 REGN Option Ex 5,819 30.63 178,235
2014-02-11 REGN Sale 5,819 325.00 1,891,175
2014-01-14 REGN Sale 4,000 290.00 1,160,000
2013-05-01 REGN Option Ex 5,875 52.03 305,676
2013-05-02 REGN Sale 2,213 244.40 540,859
2013-04-11 REGN Option Ex 5,875 30.63 179,951
2013-04-12 REGN Sale 3,129 210.31 658,047
2012-12-18 REGN Option Ex 4,625 21.25 98,281
2012-12-18 REGN Sale 752 178.95 134,568
2012-12-19 REGN Sale 1,841 177.02 325,890
2012-12-17 REGN Option Ex 5,000 16.80 84,000
2012-12-17 REGN Sale 1,000 178.82 178,820
2012-08-24 REGN Sale 6,727 144.67 973,181
2012-08-23 REGN Option Ex 15,125 25.94 392,342
2012-02-14 REGN Option Ex 35,000 20.64 722,400
2012-02-14 REGN Sale 4,562 109.75 500,702
2012-02-15 REGN Sale 9,097 111.08 1,010,494
2012-02-16 REGN Sale 5,353 107.50 575,447
2011-03-21 REGN Sale 10,600 40.02 424,212
2011-03-21 REGN Option Ex 10,600 20.32 215,392
2011-03-09 REGN Option Ex 9,400 20.32 191,008
2011-03-09 REGN Sale 9,400 40.00 376,000
2010-02-02 REGN Option Ex 5,875 10.56 62,069
2010-02-02 REGN Sale 5,875 28.00 164,500
2009-12-21 REGN Sale 2,456 22.00 54,032
2009-12-21 REGN Option Ex 2,456 8.50 20,876
2008-10-01 REGN Option Ex 5,034 11.22 56,461
2008-10-01 REGN Sale 6,341 21.90 138,874
2008-10-01 REGN Option Ex 6,341 11.71 74,278
2008-10-01 REGN Sale 4,957 21.34 105,777
2008-10-01 REGN Option Ex 4,957 11.08 54,913
2008-10-01 REGN Sale 5,034 21.71 109,298
2008-10-01 REGN Option Ex 5,034 11.22 56,461
2008-10-01 REGN Sale 6,341 21.90 138,874
2008-10-01 REGN Option Ex 6,341 11.71 74,278
2008-10-01 REGN Sale 4,957 21.34 105,777
2008-10-01 REGN Option Ex 4,957 11.08 54,913
2008-10-01 REGN Sale 5,034 21.71 109,298
2007-11-02 REGN Option Ex 6,209 8.75 54,310
2007-11-02 REGN Sale 6,209 21.00 130,407

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mccorkle Douglas S (VP, Controller and A of Regeneron Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.